Clinical Trial Update: sEphB4-HSA in Treating Patients With Kaposi Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sEphB4-HSA for Skin Kaposi sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• sEphB4-HSA

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Skin Kaposi Sarcoma | Phase 2 | Status: COMPLETED